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Abstract
Background: Diffuse alveolar haemorrhage (DAH) has been rarely reported in association with pulmonary
infections.
Case Presentation: We report the case of a 43 year old immunocompetent man presenting with dyspnoea, fever
and haemoptysis. Chest imaging showed bilateral ground glass opacities. Microbiological and molecular tests were
positive for Mycobacterium tuberculosis and treatment with isoniazid, rifampicin, ethambutol and pyrazinamide was
successful. In this case the diagnosis of DAH relies on clinical, radiological and endoscopic findings. Routine blood
tests documented the presence of anticardiolipin antibodies. In the reported case the diagnostic criteria of
antiphospholipid syndrome were not fulfilled.
Conclusions: The transient presence of anticardiolipin antibodies in association with an unusual clinical
presentation of pulmonary tuberculosis is intriguing although a causal relationship cannot be established.
Background
Diffuse alveolar haemorrhage (DAH) is a clinico-patho-
logic syndrome defined by bleeding from alveolar ves-
sels. It may be encountered inm a n yd i f f e r e nt settings,
especially in autoimmune diseases and systemic small-
vessel vasculitides, and may be linked to various histolo-
gical patterns. Pulmonary infections have been rarely
associated to DAH. The diagnosis relies upon clinical
manifestations, chest imaging, laboratory findings and
bronchoalveolar lavage (BAL) [1].
To our knowledge, pulmonary tuberculosis (TB) has
been reported only once as the cause of DAH, following
autologous stem cell transplantation for diffuse large B
cell lymphoma [2].
We report a case of culture proven pulmonary TB
presenting as DAH in an immunocompetent man with-
out other risk factors. Patient’s written consent was
obtained for the case report to be published.
Case presentation
A 43 year old non-smoking man was admitted in June
2008 because of rapidly progressive exertional dyspnoea,
fever and haemoptysis for one week. He reported three
cases of pulmonary TB in his family (his father, a sister
and an uncle). Past medical history was remarkable only
for arterial hypertension, well controlled with amlodipin.
He denied exposure to gases, fumes or toxic chemicals.
He had never taken any illicit drug in the past.
At admission the patients was dyspnoeic with 30
breaths/min. Chest examination revealed fine bilateral
rales. Physical examination of the heart revealed a regu-
lar tachycardia (110 beats/min) with normal heart
sounds and no murmurs. Arterial blood pressure was
135/90 mmHg. Abdominal findings were normal. There
were no signs of lower extremity deep venous thrombo-
sis. Wells score was -2, rendering the diagnosis of
venous thromboembolism very unlikely. Chest CT scan
showed bilateral areas of increased attenuation with a
prevalent pattern of ground glass opacities; focal areas
of consolidation and scattered micronodules could be
observed (Figure 1). We did not find upper lobe nodules
or cavities. * Correspondence: amarruchella@qubisoft.it
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anaemia (Hb 11.1 g/dl) with a normal platelet count
(118·10
3/mm
3; reference range 80-400·10
3/mm
3). Coagu-
lation function was normal (aPTT 34 sec, PT 84%, INR
1.13, fibrinogen 559 mg/dl). Urinalysis was unremark-
able. ESR 41 mm/h (reference value <15). Auto antibo-
dies (ANA, ENA, AGBM, anti-dsDNA and ANCA) and
the lupus anticoagulant test were negative. Anticardioli-
pin (aCL) IgG antibodies were found (76 UGPL; refer-
ence value <13) while anti-b2-glycoprotein-I (b2-GPI)
antibodies were absent. Tuberculin skin test (5 U PPD)
was negative such as a T-cell INF-g release assay for TB
infection (QuantiFERON-TB gold: 0.10 UI/ml; cut-off
value 0.35 UI/ml). Screening test for HIV-Ab was non
reactive. Arterial blood gases breathing room air
revealed hypoxemia (66 mmHg) and hypocapnia (31
mmHg).
Flexible bronchoscopy (FBS) showed fresh blood in all
segmental bronchi. BAL in the left upper lobe obtained
a progressively bloodier return in the five 20 ml aliquots.
Microscopy revealed red blood cells and alveolar macro-
phages (90% of total cells, lymphocytes and neutrophils
accounting for 4% and 6% respectively). About 40% of
alveolar macrophages had cytoplasmic haemosiderin
inclusions (iron staining). No tissue biopsies were taken.
Bacterioscopic examinati o no fB A La n ds p u t u mw e r e
negative for acid fast bacilli such as culture for common
bacteria, while molecular test for Mycobacterium tuber-
culosis (16S rRNA) gave a positive result in a few hours,
so that a standard therapy with isoniazid, rifampicin,
ethambutol and pyrazinamide was started on the same
day. Corticosteroids were not added to the therapy.
Fever, cough and haemoptysis resolved in the first week
while chest X-ray cleared in about 4 weeks. Cultures
grew M. tuberculosis in 21 days and drug susceptibility
test did not show any resistance to first line drugs.
After 8 weeks, anaemia resolved (Hb 14.5 g/dl) and
aCL antibodies became negative. Ethambutol and pyrazi-
namide were discontinued, and isoniazid and rifampicin
were continued for 16 weeks.
Conclusions
DAH has been reported in many clinical settings but is
often associated with autoimmune diseases or systemic
small-vessel vasculitides. Rarely drugs and chemicals have
been involved in the pathogenesis of DAH [1]. Among
pulmonary infections, there are reports relating DAH to
viruses, mycoplasma,a n dlegionella [3-5]. Pulmonary TB
has been reported in a patient presenting with DAH fol-
lowing autologous bone marrow transplantation. TB was
diagnosed post-mortem on BAL culture [2].
In this case the diagnosis of DAH relies on clinical
(haemoptysis, anaemia), radiological, endoscopic and
laboratory findings. On the other hand, the diagnosis of
pulmonary TB was established by molecular tests and
culture of BAL fluid and the causal link between TB
and DAH was strongly supported by the prompt clinical
response to anti-mycobacterial therapy. The negative
results of PPD and QuantiFERON-TB confirm the low
sensitivity of these tests in active TB making them of
limited clinical usefulness [6].
Antiphospholipid (aPL) antibodies have been found in
association with many infectious diseases: viral (HCV,
HBV, HIV, CMV, EBV, parvovirus B19, HTLV-1), bac-
terial and mycobacterial (leprosy, syphilis, rickettsiosis,
leptospirosis), and parasitic (malaria, kala-azar) infec-
t i o n s .I np a r t i c u l a rE l k a y a me ta lf o u n da C LI g Ga n d
IgM in a proportion of TB patients significantly higher
than in normal controls [7]. In these circumstances aCL
antibodies are usually not associated with anti-b2-GPI
antibodies and clinical findings of antiphospholipid syn-
drome (thrombotic and haematological). On the other
hand DAH has been described in patients with antipho-
spholipid syndrome (APS) [8]. In this case the diagnostic
criteria of APS were not fulfilled. However, the transient
presence of aCL antibodies in association with an unu-
sual clinical presentation of TB is intriguing, although a
causal relationship cannot be established.
To our knowledge this is the first reported case of
pulmonary TB associated with a clinical picture of DAH
in an immunocompetent patient without other risk fac-
tors. We suggest that an infectious cause should always
be searched for in the diagnostic work-up of DAH
because of obvious therapeutic implications. Molecular
tests for M. tuberculosis may be of value, allowing for a
timely diagnosis and prompt therapy. The prevalence
and possible pathogenic role of aPL antibodies in patient
with TB should be explored in a prospective manner.
Figure 1 Chest CT scan at the level of main carina, showing
bilateral areas of increased attenuation with a prevalent
pattern of ground glass opacities. Scattered micronodules can be
observed.
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ANA: antinuclear antibodies; ENA: extractable nuclear antigens; AGBM: anti-
glomerular basement membrane; ANCA: anti-neutrophil cytoplasmic
antibodies; HCV: hepatitis C virus; HBV: hepatitis B virus; HIV: human
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